Gilles Hittinger

2.3k total citations
19 papers, 514 citations indexed

About

Gilles Hittinger is a scholar working on Virology, Infectious Diseases and Oncology. According to data from OpenAlex, Gilles Hittinger has authored 19 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 17 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Gilles Hittinger's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (12 papers). Gilles Hittinger is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (12 papers). Gilles Hittinger collaborates with scholars based in France, United States and Germany. Gilles Hittinger's co-authors include Alain Lafeuillade, Cécile Poggi, Philippe Halfon, Caroline Solas, Bruno Lacarelle, N. Profizi, D Émilie, E. Counillon, Hacène Khiri and S. Chadapaud and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and AIDS.

In The Last Decade

Gilles Hittinger

19 papers receiving 497 citations

Peers

Gilles Hittinger
Comparison fields: 5 of 45
  • Virology 465
  • Infectious Diseases 398
  • Emergency Medicine 108
  • Immunology 83
  • Epidemiology 78
Richard Loftus United States
Radjin Steingrover Netherlands
Rieneke M. E. van Praag Netherlands
Joon Chang Australia
Laura P. Kincer United States
Audrey Taïeb France
Zacarias da Silva Guinea-Bissau
Michela Violin Italy
Marie Fuerst United States
Piera Pierotti Italy
Richard Loftus United States View profile →
Citations per field, relative to Gilles Hittinger
Gilles Hittinger · 1×
Citations per year, relative to Gilles Hittinger
Gilles Hittinger · 1×

Countries citing papers authored by Gilles Hittinger

Since Specialization
Citations

This map shows the geographic impact of Gilles Hittinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Hittinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Hittinger more than expected).

Fields of papers citing papers by Gilles Hittinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Hittinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Hittinger. The network helps show where Gilles Hittinger may publish in the future.

Co-authorship network of co-authors of Gilles Hittinger

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Hittinger. A scholar is included among the top collaborators of Gilles Hittinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Hittinger. Gilles Hittinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
# Title Journal Authors Indexed citations
1 Drug interactions in the elderly HIV‐infected patient Journal of the International AIDS Society Gilles Hittinger, Saadia Mokhtari et al. 1
2 HIV-1 Meningoencephalitis in Patients on Effective HAART HIV Clinical Trials Alain Lafeuillade, Antoine Chéret et al. 2
3 Rectal Cell-Associated HIV-1 RNA: A New Marker Ready for the Clinic HIV Clinical Trials Alain Lafeuillade, Antoine Chéret et al. 11
4 Highlights from the 13th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) HIV Clinical Trials Alain Lafeuillade, Caroline Solas et al. 1
5 Predictors of Plasma Human Immunodeficiency Virus Type 1 RNA Control after Discontinuation of Highly Active Antiretroviral Therapy Initiated at Acute Infection Combined with Structured Treatment Interruptions and Immune‐Based Therapies The Journal of Infectious Diseases Alain Lafeuillade, Cécile Poggi et al. 42
6 Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlations HIV Clinical Trials Alain Lafeuillade, Caroline Solas et al. 64
7 Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy Caroline Solas, Alain Lafeuillade et al. 145
8 HIV-1 Induction-Maintenance at the Lymph Node Level: The “Apollo-97” Study JAIDS Journal of Acquired Immune Deficiency Syndromes Alain Lafeuillade, Cécile Poggi et al. 1
9 Pilot Study of a Combination of Highly Active Antiretroviral Therapy and Cytokines to Induce HIV-1 Remission JAIDS Journal of Acquired Immune Deficiency Syndromes Alain Lafeuillade, Cécile Poggi et al. 44
10 Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV‐1 clinical isolates HIV Medicine Alain Lafeuillade, Cécile Poggi et al. 11
11 Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART AIDS Alain Lafeuillade, Hacène Khiri et al. 22
12 Impact of immune interventions on proviral HIV‐1 DNA decay in patients receiving highly active antiretroviral therapy HIV Medicine Alain Lafeuillade, Cécile Poggi et al. 21
13 HIV-1 Induction-Maintenance at the Lymph Node Level: The “Apollo-97” Study JAIDS Journal of Acquired Immune Deficiency Syndromes Alain Lafeuillade, Cécile Poggi et al. 1
14 Pilot Study of a Combination of Highly Active Antiretroviral Therapy and Cytokines to Induce HIV-1 Remission JAIDS Journal of Acquired Immune Deficiency Syndromes Alain Lafeuillade, Cécile Poggi et al. 12
15 Potential Adverse Effects of Structured Therapeutic Interruptions on the Pool of HIV-Infected Cells JAIDS Journal of Acquired Immune Deficiency Syndromes Alain Lafeuillade, Philippe Halfon et al. 1
16 Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infection AIDS Cécile Poggi, N. Profizi et al. 23
17 Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients Infection Gilles Hittinger, Cécile Poggi et al. 33
18 Residual Human Immunodeficiency Virus Type 1 RNA in Lymphoid Tissue of Patients with Sustained Plasma RNA of <200 Copies/mL The Journal of Infectious Diseases Alain Lafeuillade, Gilles Hittinger et al. 59
19 Lymph Node Expansion of CD4+Lymphocytes during Antiretroviral Therapy The Journal of Infectious Diseases Alain Lafeuillade, Gilles Hittinger et al. 20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026